About
Roger Franklin trained as a scientist, completing doctoral work at Cambridge's Laboratory of Molecular Biology (LMB), and has since worked across venture capital, investment banking, and strategy consulting for nearly two decades. Before joining Hadean Ventures in 2018 to lead its Stockholm office, he was a pharmaceutical and biotechnology analyst at the investment bank Liberum in London. At Hadean, he focuses on therapeutic-space investments.
Invests in
Biotech
Investments
Board seats
AblivaCardior PharmaceuticalsComplement TherapeuticsContineum TherapeuticsEmergence TherapeuticsGesynta PharmaStep PharmaTarged Biopharmaceuticals
Per the firm's website.
Colleagues at Hadean Ventures
Camilla Olsen
Impact & ESG Manager at Hadean Ventures
Dustin Zielinski
Investment Analyst at Hadean Ventures
Florian Eckhardt
Senior Advisor at Hadean Ventures
Georgina Askeland
Principal at Hadean Ventures
Ingrid Beyer
Senior Advisor at Hadean Ventures
Ingrid Teigland Akay
Managing Partner at Hadean Ventures
Jan Kästingschäfer
Project Analyst at Hadean Ventures
Lene Dragesund
Senior Office Manager at Hadean Ventures
Frequently asked questions
- Where does Roger Franklin work?
- Roger Franklin is Partner at Hadean Ventures.
- What does Roger Franklin invest in?
- Roger Franklin invests in Biotech.